Yi Zhang
Senior Scientist And Group Leader In Cancer Immunotherapy @ Eli Lilly and Company
About Yi Zhang
Yi Zhang is a Senior Scientist and Group Leader in Cancer Immunotherapy at Eli Lilly and Company, where he has worked since 2009. He specializes in bispecific antibody platform development and has received multiple awards for his contributions to cancer research.